MedTrace Logo

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

NCT02739659 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2021-11-19

No results posted yet for this study

Summary

The aim of this research project is to assess the feasibility and safety of carbon-ion radiotherapy (CIRT) for the treatment of in Chinese localized prostate cancer

Conditions

  • Prostate Carcinoma

Interventions

DEVICE

carbon-ion radiotherapy

Sponsors & Collaborators

  • Shanghai Proton and Heavy Ion Center

    lead OTHER

Principal Investigators

  • Qing Zhang, Dr. · Shanghai Proton and Heavy Ion Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2022-12-01
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02739659 on ClinicalTrials.gov